BEAM
Price
$30.43
Change
-$2.71 (-8.18%)
Updated
Feb 21 closing price
Capitalization
2.52B
9 days until earnings call
VKTX
Price
$34.07
Change
+$2.44 (+7.71%)
Updated
Feb 21 closing price
Capitalization
3.8B
59 days until earnings call
Ad is loading...

BEAM vs VKTX

Header iconBEAM vs VKTX Comparison
Open Charts BEAM vs VKTXBanner chart's image
Beam Therapeutics
Price$30.43
Change-$2.71 (-8.18%)
Volume$1.88M
Capitalization2.52B
Viking Therapeutics
Price$34.07
Change+$2.44 (+7.71%)
Volume$15.77M
Capitalization3.8B
BEAM vs VKTX Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. VKTX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and VKTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (BEAM: $30.43 vs. VKTX: $34.07)
Brand notoriety: BEAM and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 152% vs. VKTX: 357%
Market capitalization -- BEAM: $2.52B vs. VKTX: $3.8B
BEAM [@Biotechnology] is valued at $2.52B. VKTX’s [@Biotechnology] market capitalization is $3.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • VKTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both BEAM and VKTX are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -6.08% price change this week, while VKTX (@Biotechnology) price change was +11.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

VKTX is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.8B) has a higher market cap than BEAM($2.52B). BEAM YTD gains are higher at: 22.702 vs. VKTX (-15.333). VKTX has higher annual earnings (EBITDA): -133.66M vs. BEAM (-160.83M). VKTX (930M) and BEAM (926M) have equal amount of cash in the bank . VKTX has less debt than BEAM: VKTX (1.24M) vs BEAM (162M). BEAM has higher revenues than VKTX: BEAM (350M) vs VKTX (0).
BEAMVKTXBEAM / VKTX
Capitalization2.52B3.8B66%
EBITDA-160.83M-133.66M120%
Gain YTD22.702-15.333-148%
P/E RatioN/AN/A-
Revenue350M0-
Total Cash926M930M100%
Total Debt162M1.24M13,117%
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMVKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMCTX34.50N/A
N/A
Lord Abbett Mid Cap Stock R5
LIDOX8.60N/A
N/A
Lord Abbett International Value F3
ETNEX14.08N/A
N/A
Eventide Exponential Technologies N
MDDCX23.74-0.16
-0.67%
BlackRock Emerging Mkts Inv A
RLBAX34.95-0.35
-0.99%
American Funds American Balanced R1

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with JANX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+7.71%
JANX - VKTX
61%
Loosely correlated
-3.12%
DNLI - VKTX
48%
Loosely correlated
-3.98%
LGND - VKTX
44%
Loosely correlated
-1.10%
ALT - VKTX
42%
Loosely correlated
-3.02%
BEAM - VKTX
40%
Loosely correlated
-8.18%
More